Drug · DIN 02027860
DAYPRO
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 20, 2012; first marketed January 7, 1997.
- Drug Identification Number (DIN)
- 02027860
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Oxaprozin M01AE12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OXAPROZIN | 600 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 9, 2003: NOC 3420New Drug Submission (NDS) · Manufacturer name change
- April 20, 2001: NOC 2496New Drug Submission (NDS) · New manufacturer name